(Total Views: 235)
Posted On: 09/08/2022 1:15:48 PM
Post# of 45

$ZYNE News Article - Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium https://marketwirenews.com/news-releases/zyne...48335.html


My Twitter: WhyteStocks